1. The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial 
Patrick J Stiff, Joseph M Unger, Stephen J Forman, Anne R McCall, Michael LeBlanc, Auayporn P Nademanee, Brian J Bolwell, Richard I Fisher 
Biology of Blood and Marrow Transplantation 
Volume 9, Issue 8, Pages (August 2003)
DOI: /S (03)

2. Figure 1 Progression-free survival based on disease sensitivity.
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )

3. Figure 2 Overall survival based on disease sensitivity.
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )

4. Figure 3 Progression-free survival based on preparative regimen.
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )

5. Figure 4 Overall survival based on preparative regimen.
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )

6. Figure 5
Overall survival by number of risk factors: >2 prior chemotherapy regimens, extranodal disease, and relapse in prior radiation field. Hazard ratio: 2.26 (95% CI, 1.01– 5.07).
Biology of Blood and Marrow Transplantation 2003 9, DOI: ( /S (03) )